Giant-cell myocarditis management using short-term TandemHeart support, MANTA closure device, and combination immunosuppression.
We present the case of a 53-year-old woman who presented to the hospital with palpitations and fatigue. The workup revealed new-onset systolic heart failure secondary to giant cell myocarditis. She developed cardiogenic shock, which was managed with the TandemHeart left ventricular assist device and combination immunosuppression strategy. This article highlights our management approach that avoided the need for an urgent heart transplant.
Published In/Presented At
Sagheer, S., Nagahama, M., Prejean, S., Ahmed, M., Gangwani, M. K., Litovsky, S., Lenneman, A., Rajapreyar, I., Tallaj, J. A., & Joly, J. (2021). Giant-cell myocarditis management using short-term TandemHeart support, MANTA closure device, and combination immunosuppression. Proceedings (Baylor University. Medical Center), 35(2), 214–216. https://doi.org/10.1080/08998280.2021.1997047
Medicine and Health Sciences
Department of Medicine, Cardiology Division, Department of Medicine Fellows and Residents, Fellows and Residents